NCT01033435

Brief Summary

The current study will investigate chronic hemodialysis patients who were treated in our unit with pomegranate juice intake for 1 year - compared to a control group. Markers will be taken 3 months after cessation of pomegranate juice intake, for inflammation and oxidative stress and Hb A1c.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2009

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 16, 2009

Completed
1.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

August 17, 2011

Status Verified

August 1, 2011

First QC Date

December 15, 2009

Last Update Submit

August 16, 2011

Conditions

Keywords

InflammationOxidative stressHbA1cHemodialysis

Study Arms (2)

chronic Hemodialysis patients, treated in our unit.

Other: No intervention

chronic Hemodialysis patients , No intervention

chronic Hemodialysis patients, treated in our unit.

Interventions

chronic Hemodialysis patients, treated in our unit.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

chronic Hemodialysis patients, treated in our unit.

You may qualify if:

  • Chronic Hemodialysis patients three months after termination of study which is currently carried out at our unit; which compared patients taking pomegranate juice three times a week for 1 year to a group that received placebo juice.

You may not qualify if:

  • Patients who do not currently participate in above mentioned trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Western Galilee Hospital

Nahariya, Western Galilee, 25100, Israel

Location

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

December 15, 2009

First Posted

December 16, 2009

Study Start

December 1, 2009

Study Completion

August 1, 2011

Last Updated

August 17, 2011

Record last verified: 2011-08

Locations